The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Americas Dengue Prevention Board on August 3-4, 2017 in São Paulo, Brazil.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Americas region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

"> The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Americas Dengue Prevention Board on August 3-4, 2017 in São Paulo, Brazil.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Americas region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

" /> Americas Dengue Prevention Board Meeting 2017 - Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC)

  • news

    Americas Dengue Prevention Board Meeting 2017

Back

August 3-4, 2017 - São Paulo (Brazil)

The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Americas Dengue Prevention Board on August 3-4, 2017 in São Paulo, Brazil.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Americas region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

Back to the list